Advances in high-throughput screening approaches for biosurfactants: current trends, bottlenecks and perspectives

被引:0
|
作者
Qazi, Muneer Ahmed [1 ,2 ,3 ,4 ]
Phulpoto, Irfan Ali [4 ,5 ]
Wang, Qinhong [1 ,2 ,3 ]
Dai, Zongjie [1 ,2 ,3 ,6 ]
机构
[1] Chinese Acad Sci, Key Lab Engn Biol Low Carbon Mfg, Tianjin, Peoples R China
[2] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China
[3] Natl Ctr Technol Innovat Synthet Biol, Tianjin, Peoples R China
[4] Shah Abdul Latif Univ, Inst Microbiol, Fac Nat Sci, Khairpur, Pakistan
[5] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China
[6] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, TIB VIB Joint Ctr Synthet Biol, 32 West 7th Ave, Tianjin 300308, Peoples R China
关键词
Biosurfactants; mutagenesis; high-throughput screening; miniaturization; fluorescent-activated cell sorting; colorimetric detection; SURFACE-ACTIVE COMPOUNDS; GLYCOLIPID BIOSURFACTANTS; LIPIDS BIOSURFACTANTS; RANDOM MUTAGENESIS; STRAIN; OIL; RHAMNOLIPIDS; IMPROVEMENT; BACTERIA; ISOLATE;
D O I
10.1080/07388551.2023.2290981
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The market size of biosurfactants (BSs) has been expanding at an extremely fast pace due to their broad application scope. Therefore, the re-construction of cell factories with modified genomic and metabolic profiles for desired industrial performance has been an intriguing aspect. Typical mutagenesis approaches generate huge mutant libraries, whereas a battery of specific, robust, and cost-effective high-throughput screening (HTS) methods is requisite to screen target strains for desired phenotypes. So far, only a few specialized HTS assays have been developed for BSs that were successfully applied to obtain anticipated mutants. The most important milestones to reach, however, continue to be: specificity, sensitivity, throughput, and the potential for automation. Here, we discuss important colorimetric and fluorometric HTS approaches for possible intervention on automated HTS platforms. Moreover, we explain current bottlenecks in developing specialized HTS platforms for screening high-yielding producers and discuss possible perspectives for addressing such challenges. [GRAPHICS]
引用
收藏
页数:19
相关论文
共 50 条
  • [2] High-Throughput Screening in Protein Engineering: Recent Advances and Future Perspectives
    Wojcik, Magdalena
    Telzerow, Aline
    Quax, Wim J.
    Boersma, Ykelien L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (10): : 24918 - 24945
  • [3] Assessing high-throughput screening advances
    Hefti, E
    Bolten, BM
    GENETIC ENGINEERING NEWS, 2003, 23 (21): : 7 - +
  • [4] Technological advances in high-throughput screening
    Fernandes, PB
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (05) : 597 - 603
  • [5] Emerging trends in high-throughput screening
    Entzeroth, M
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (05) : 522 - 529
  • [6] Novel trends in high-throughput screening
    Mayr, Lorenz M.
    Bojanic, Dejan
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (05) : 580 - 588
  • [7] Approaches to automation for high-throughput screening
    Reichman, M
    Marples, E
    Lenz, S
    LABORATORY ROBOTICS AND AUTOMATION, 1996, 8 (05) : 267 - 276
  • [8] High-throughput screening for integrative biomaterials design: exploring advances and new trends
    Oliveira, Mariana B.
    Mano, Joao F.
    TRENDS IN BIOTECHNOLOGY, 2014, 32 (12) : 627 - 636
  • [9] High-throughput screening: advances in assay technologies
    Sittampalam, GS
    Kahl, SD
    Janzen, WP
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (03) : 384 - 391
  • [10] Advances, practice, and clinical perspectives in high-throughput sequencing
    Park, S-J
    Saito-Adachi, M.
    Komiyama, Y.
    Nakai, K.
    ORAL DISEASES, 2016, 22 (05) : 353 - 364